Michelle Baxter

Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase

Sridhar K. Rabindran, Carolyn Discafani, Edward Rosfjord et al. · Cancer Research · 2004 · 638 citations · Full text

Medicine, Oncology, Pharmacology +13

HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo.

Frank Loganzo, Carolyn Discafani, Tami Annable et al. · PubMed · 2003 · 137 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Delineation of a Cellular Hierarchy in Lung Cancer Reveals an Oncofetal Antigen Expressed on Tumor-Initiating Cells

Marc Damelin, Kenneth G. Geles, Maximillian T. Follettie et al. · Cancer Research · 2011 · 81 citations

Medicine, Cancer Biology, Oncology +16

Preclinical Pharmacologic Evaluation of MST-997, an Orally Active Taxane with Superior <i>In vitro</i> and <i>In vivo</i> Efficacy in Paclitaxel- and Docetaxel-Resistant Tumor Models

Deepak Sampath, Lee M. Greenberger, Carl F. Beyer et al. · Clinical Cancer Research · 2006 · 23 citations

Medicine, Oncology, Pharmacology +17

Upregulation of RNA Processing Factors in Poorly Differentiated Lung Cancer Cells

Kenneth G. Geles, Wenyan Zhong, Siobhan O’Brien et al. · Translational Oncology · 2016 · 10 citations · Full text

Medicine, Molecular Biology, Oncology +16